Cannabis vape sales tumbled 26 per cent in the two months following the health crisis that has killed dozens and sickened thousands, according to new industry research.
Legal sales peaked at a combined US$160 million in August in the states of California, Colorado, Oregon, Nevada and Arizona, according to a report from BDS Analytics and Arcview Market Research.
As reports of vaping illnesses grew and the Centers for Disease Control and Prevention disclosed the first deaths related to the practice, sales slumped to US$126 million in September and US$119 million in October. This was significant for the legal cannabis market as a whole, where vapes accounted for approximately 25 per cent of total sales in the first three quarters of 2019.
“The news from the CDC, and the wide and immediate spread of information and misinformation in its aftermath, quickly took its toll,” BDS and Arcview said in their report.
It appears the damage didn’t spread much beyond the vape category, as September sales of all non-vape products fell 4.6 per cent, only slightly more than the 4.1 per cent decline in the prior September, which is traditionally a slow month.